Any discrepancy should be isolated and reported through the PEPTAS quality-claim process
Concurrent insulin resistance (fasting insulin above 15 mIU/L) suppressing HSL activity independent of genetics
For a standard 5mg dose from 50mg powder, add 2.5mL bacteriostatic water to create a 20mg/mL solution
Researchers studying nutrient-based metabolic support should use this lipotropic compound
Follow-up laboratory testing should occur 8-12 weeks after initiating supplementation to confirm adequate response, with ongoing monitoring as clinically indicated
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence